Basel, Switzerland

Achim Guettner

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Achim Guettner. Retrieved from https://idiyas.com/inventor/achim-guettner-uzs5rl2z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Achim Guettner: Innovator in the Pharmaceutical Industry

Introduction

Achim Guettner is a notable inventor based in Basel, Switzerland. He is currently associated with Novartis AG, a leading global healthcare company. Despite having no patents to his name, his contributions to the field of pharmaceuticals are significant.

Latest Patents

Achim Guettner currently holds 3 patents. This indicates that his work may focus more on research and development rather than patenting inventions.

Career Highlights

Throughout his career, Achim has been involved in various projects that aim to improve healthcare solutions. His role at Novartis AG allows him to collaborate with some of the brightest minds in the industry, contributing to innovative healthcare advancements.

Collaborations

Achim works alongside Charis Papavassilis, with whom he shares a commitment to advancing pharmaceutical research. Their collaboration exemplifies the importance of teamwork in achieving groundbreaking results in the healthcare sector.

Conclusion

Achim Guettner's journey in the pharmaceutical industry highlights the value of collaboration and innovation, even in the absence of patents. His work at Novartis AG continues to contribute to the advancement of healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…